Lysergine

Lysergine
Clinical data
Other names9,10-Didehydro-6,8β-dimethylergoline
ATC code
  • None
Identifiers
  • (6aR,9R)-7,9-dimethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H18N2
Molar mass238.334 g·mol−1
3D model (JSmol)
  • C[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
  • InChI=1S/C16H18N2/c1-10-6-13-12-4-3-5-14-16(12)11(8-17-14)7-15(13)18(2)9-10/h3-6,8,10,15,17H,7,9H2,1-2H3/t10-,15-/m1/s1
  • Key:YOZGACBWDKFAAD-MEBBXXQBSA-N

Lysergine, also known as 9,10-didehydro-6,8β-dimethylergoline, is an ergot alkaloid and serotonin receptor agonist of the ergoline family. It is a minor constituent of ergot.

Pharmacology

Lysergine shows selectivity for activation of the serotonin 5-HT2A receptor over several other closely related serotonin receptors (54-fold over the 5-HT2B receptor, 38-fold over the 5-HT2C receptor, and 127-fold over the 5-HT1A receptor). The drug is a partial agonist of the 5-HT2A receptor with moderate intrinsic activity (Emax = 57%).

Lysergine activation of serotonin receptors
5-HT1A5-HT2A5-HT2B5-HT2C
EC50EmaxEC50EmaxEC50EmaxEC50Emax
342 ± 23ND2.7 ± 1.657%145 ± 5436%103 ± 942%
Notes: EC50 values are nanomolar (nM) and EC50 values are mean ± SEM.

An analogue of lysergine, (+)-13-fluorolysergol, is an even more selective agonist of the 5-HT2A receptor than lysergine (EC50 for 5-HT2B and 5-HT2C of >10,000 nM). However, this compound has relatively weak maximal efficacy in activating the receptor (Emax = 17%).

Chemistry

Analogues

Isotryptamine or JRT-type analogues of lysergine have been described.

See also